Non-HDL Cholesterol Helps Predict Heart Risk

Their findings were reported in the October 22, 2002, issue of Circulation.

Reducing low-density lipoprotein (LDL) cholesterol has long been the goal of medications and other cholesterol-lowering treatments. Now, researchers are finding that other lipoproteins appear to be involved in developing heart disease. These include some very low-density lipoproteins (VLDL) and intermediate-density lipoproteins (IDL), both of which are types of non-HDL cholesterol.

The researchers studied data compiled previously during the Bypass Angioplasty Revascularization Investigation (BARI) trial, a study that followed 1,514 heart patients (73 percent male, average age 61 years) for five years, checking their cholesterol levels throughout the study period and recording their health histories. They found that non-HDL cholesterol is a strong and independent predictor of non-fatal heart attack and angina (chest pain or discomfort) at five years, even after considering other risk factors, such as age and smoking. The latest version of the US National Cholesterol Education Program (NCEP) guidelines recommends that doctors first target LDL cholesterol, but also pay attention to non-HDL cholesterol.

"LDL cholesterol, even though it is a ‘bad' cholesterol, tells only part of the story,” says lead author Vera Bittner, M.D., MSPH, professor of medicine at the University of Alabama at Birmingham (Tuscaloosa, USA; www.ua.edu). "We found that while LDL cholesterol is important, the non-HDL cholesterol is the more important predictor, at least in this group of people with heart disease.”



Related Links:
U. of Alabama